Skip to content
Merevedési zavar

Merevedési zavar kezelések

Bongéssze az elérheeto merevedési zavar kezeléseket. Mindegyik tartalmazza a fuggetlen EU-s orvos felulvizsgalatát, eredeti gyogyszereket engedélyes gyogyszertarakbol és diszkret expressz kézbesitést.

2026-04-12 Kezelések

Interested in Merevedési zavar?

Complete a confidential health assessment reviewed by an independent EU-registered doctor.

Start Assessment

Erectile dysfunction kezelések Európában

Erectile dysfunction (ED) — defined as the persistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance — is one of the most prevalent male health conditions in Europe. Clinical studies estimate that ED affects approximately 19–52% of men between the ages of 40 and 70, with prevalence increasing markedly with age. Despite this, it remains significantly undertreated, with many men not seeking help due to embarrassment or a lack of accessible, confidential services.

ED can have both psychological and physiological causes, and in most cases the two are interrelated. Physiological factors include cardiovascular disease, diabetes, hypertension, hyperlipidaemia, hormonal imbalances, and neurological conditions. Lifestyle factors — including smoking, excessive alcohol consumption, obesity, and physical inactivity — are also established risk factors. Psychological contributors include performance anxiety, relationship difficulties, depression, and stress.

Critically, erectile dysfunction is recognised by European cardiovascular guidelines as a potential early marker of atherosclerosis and future cardiac events. Men presenting with new-onset ED should be evaluated for cardiovascular risk factors by a qualified clinician.

The first-line pharmacological treatment for ED is the class of drugs known as phosphodiesterase type 5 (PDE5) inhibitors. These medications enhance the natural physiological pathway that produces an erection in response to sexual stimulation — they do not produce erections independently and are not effective without arousal. Four PDE5 inhibitors are currently EMA-approved: sildenafil, tadalafil, vardenafil, and avanafil.

Elérhető kezelések

The following EMA-approved prescription medications are available for erectile dysfunction through EU-registered doctors. This comparison is provided for informational purposes only.

MedicationActive IngredientOnsetDurationNotes
SildenafilSildenafil citrate30–60 min4–6 hoursGeneric available; original Viagra
TadalafilTadalafil30–60 minUp to 36 hoursAlso available as daily 5 mg dose
VardenafilVardenafil HCl25–60 min4–6 hoursAlso available as orodispersible tablet
AvanafilAvanafil15–30 min6–12 hoursFastest onset; fewer food/alcohol interactions

Key distinctions:

  • Sildenafil: The most widely prescribed PDE5 inhibitor globally. Generic versions are available in most EU countries, making it typically the most cost-accessible option.
  • Tadalafil: The longest duration of action, earning it the informal name “the weekend pill.” The daily low-dose formulation (5 mg) allows spontaneous sexual activity without planning around timing.
  • Vardenafil: Similar efficacy profile to sildenafil. The orodispersible (dissolving tablet) formulation provides a discreet and convenient alternative to standard tablets.
  • Avanafil: The newest approved PDE5 inhibitor. Its faster onset and more selective mechanism may result in fewer side effects in some men, though individual response varies.

Hogyan szerezhető be a kezelések online

A Prescrivia technológiai közvetítőként működik: nem írunk fel gyógyszereket, nem alkalmazunk orvosokat és nem értékesítünk gyógyszereket. Platformunk pácienseket kapcsol össze független, EU-ban regisztrált orvosokkal, akik bizalmas online egészségügyi felméréseket végezhetnek.

A folyamat a következő:

  1. Töltse ki az egészségügyi kérdőívet — Answer a structured set of medical questions covering the nature and duration of your ED, cardiovascular health, diabetes status, current medications (particularly nitrates or alpha-blockers), blood pressure, and lifestyle factors.

  2. Independent doctor review — An independent EU-registered doctor reviews your assessment. If a PDE5 inhibitor is clinically appropriate, the doctor may issue a prescription. If contraindications are identified, the doctor will explain and may suggest in-person follow-up.

  3. Recept és teljesítés — If a prescription is issued, it is passed to a licensed EU pharmacy partner. Medication is dispensed and delivered discreetly to your address.

Fontos: A Prescrivia nem garantálja a recept kiállítását. Minden felírási döntést független, képzett orvosok hoznak az Ön egyéni klinikai körülményei alapján.

Összehasonlításunk

A Prescrivia-n keresztülSzemélyes orvosi konzultáció
Elérhetőség24/7 online assessmentSubject to appointment availability
Várakozási időAssessment reviewed within hoursDays to weeks depending on location
Utazás szükségesNoYes
BizalmasságFull GDPR-compliant data protectionStandard clinical confidentiality
Felírási döntésMade by independent EU-registered doctorMade by your GP
KöltségTransparent pricing displayed upfrontVaries by country and healthcare system

Note: ED associated with chest pain, severe cardiovascular disease, recent heart attack or stroke, or other complex comorbidities requires in-person specialist evaluation before any pharmacological treatment is considered. Prescrivia’s platform is designed for adults whose ED profile is suitable for remote assessment.

Források

Az oldalon található orvosi információk az alábbi forrásokon alapulnak:

  • European Medicines Agency (EMA). Viagra/sildenafil — Summary of Product Characteristics. Available at: ema.europa.eu
  • Feldman HA, et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. Journal of Urology. 1994;151(1):54-61.
  • Vlachopoulos CV, et al. Erectile dysfunction as a cardiovascular risk factor. European Heart Journal. 2013.

Ez a tartalom rendszeresen felülvizsgálatra kerül a frissített klinikai irányelvek tükrözése érdekében. Kizárólag tájékoztató jelleggel készült, és nem minősül orvosi tanácsadásnak. Mindig konzultáljon képzett egészségügyi szakemberrel az Ön egyéni egészségügyi körülményeire vonatkozó tanácsért.

Frequently asked questions

Megkaphatom a Merevedési zavar készítményt online Európában?
A készítményhez online közvetítő platformokon keresztül férhet hozzá, amelyek független, EU-ban regisztrált orvosokkal kötik össze Önt. A bizalmas egészségügyi kérdőív kitöltése után az orvos felméri, hogy a gyógyszer klinikailag megfelelő-e az Ön számára.
Mi a különbség between sildenafil and tadalafil?
Both are PDE5 inhibitors that work by the same mechanism, but they differ primarily in duration of action. Sildenafil works for approximately 4–6 hours and is typically taken 30–60 minutes before activity. Tadalafil lasts up to 36 hours and is also available as a once-daily low-dose formulation for spontaneous use.
Vannak-e newer ED medications beyond sildenafil?
Yes. Vardenafil and avanafil are also EMA-approved PDE5 inhibitors. Avanafil has a faster onset than sildenafil — effects can begin within 15 minutes for some men. The most appropriate choice depends on individual health factors and preference, which the reviewing doctor will assess.
Biztonságos-e to take ED medication with other medications?
PDE5 inhibitors are contraindicated with nitrate medications (commonly used for chest pain and heart conditions), as the combination can cause a dangerous drop in blood pressure. Other drug interactions also exist. This is why a medical assessment is required before any prescription is issued.
Can erectile dysfunction indicate a more serious health problem?
ED can be an early warning sign of cardiovascular disease, diabetes, hypertension, or hormonal imbalances. The health assessment includes questions to screen for relevant risk factors. If warranted, the reviewing doctor may recommend further investigation before or alongside treatment.
A Prescrivia közvetítő platform. Nem nyújtunk orvosi szolgáltatásokat, nem írunk fel kezeléseket és nem adunk ki gyógyszereket. Minden orvosi döntést független, EU-ban regisztrált orvosok hoznak. Minden gyógyszert engedéllyel rendelkező EU-gyógyszertárak adnak ki. Ez a platform összeköti a betegeket és az egészségügyi szolgáltatókat.

Written by Prescrivia Editorial. Medical information sourced from European Medicines Agency (EMA), World Health Organization (WHO), and published clinical data.

This content is informational only and does not constitute medical advice.

Last updated:

Készen áll a kezdésre?

Töltse ki a bizalmas egészségügyi felmérést körülbelül 3 perc alatt.